Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

tirapazamine

(TEER-uh-PA-zuh-meen)

A substance that has been studied in the treatment of some types of cancer. It may cause damage to the DNA in cells that have a low level of oxygen, including cancer cells. This may make the cells easier to kill with radiation therapy and chemotherapy. Tirapazamine is a type of radiosensitizing agent and a type of chemosensitizing agent.

tirapazamine

Search NCI's Dictionary of Cancer Terms